233 related articles for article (PubMed ID: 14521808)
1. Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia.
Meshinchi S; Smith FO; Arceci RJ
Curr Oncol Rep; 2003 Nov; 5(6):489-97. PubMed ID: 14521808
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia.
Meshinchi S; Arceci RJ
Oncologist; 2007 Mar; 12(3):341-55. PubMed ID: 17405900
[TBL] [Abstract][Full Text] [Related]
3. Adult acute leukemia.
Cripe LD
Curr Probl Cancer; 1997; 21(1):1-64. PubMed ID: 9058027
[TBL] [Abstract][Full Text] [Related]
4. Drug resistance in childhood acute myeloid leukemia.
Styczynski J
Curr Pharm Biotechnol; 2007 Apr; 8(2):59-75. PubMed ID: 17430154
[TBL] [Abstract][Full Text] [Related]
5. Pediatric AML: past, present, and future.
Onel K; Steinherz PG
Cancer Invest; 2002; 20(7-8):1117. PubMed ID: 12449745
[No Abstract] [Full Text] [Related]
6. Pediatric acute myeloid leukemia: towards high-quality cure of all patients.
Kaspers GJ; Zwaan CM
Haematologica; 2007 Nov; 92(11):1519-32. PubMed ID: 18024401
[TBL] [Abstract][Full Text] [Related]
7. Treatment of childhood acute myeloid leukemia.
ter Bals E; Kaspers GJ
Expert Rev Anticancer Ther; 2005 Oct; 5(5):917-29. PubMed ID: 16221060
[TBL] [Abstract][Full Text] [Related]
8. Therapy of acute myeloid leukemia: towards a patient-oriented, risk-adapted approach.
Mandelli F; Petti MC; Lo Coco F
Haematologica; 1998 Nov; 83(11):1015-23. PubMed ID: 9864924
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo drug resistance in childhood acute myeloid leukemia on relapse is not higher than at first diagnosis.
Styczynski J; Wysocki M
Pediatr Blood Cancer; 2004 Feb; 42(2):195-9. PubMed ID: 14752887
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostics and therapy of acute myeloid leukemia].
Fritsch S; Metzeler K; Hiddemann W; Buske C
Dtsch Med Wochenschr; 2006 Oct; 131(43):2401-6. PubMed ID: 17054056
[No Abstract] [Full Text] [Related]
11. Acute myelogenous leukemia stem cells: from Bench to Bedside.
Felipe Rico J; Hassane DC; Guzman ML
Cancer Lett; 2013 Sep; 338(1):4-9. PubMed ID: 22713929
[TBL] [Abstract][Full Text] [Related]
12. Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology.
Aladjidi N; Auvrignon A; Leblanc T; Perel Y; Bénard A; Bordigoni P; Gandemer V; Thuret I; Dalle JH; Piguet C; Pautard B; Baruchel A; Leverger G;
J Clin Oncol; 2003 Dec; 21(23):4377-85. PubMed ID: 14645428
[TBL] [Abstract][Full Text] [Related]
13. Prognostic index for adult patients with acute myeloid leukemia in first relapse.
Breems DA; Van Putten WL; Huijgens PC; Ossenkoppele GJ; Verhoef GE; Verdonck LF; Vellenga E; De Greef GE; Jacky E; Van der Lelie J; Boogaerts MA; Löwenberg B
J Clin Oncol; 2005 Mar; 23(9):1969-78. PubMed ID: 15632409
[TBL] [Abstract][Full Text] [Related]
14. The search for optimal treatment in relapsed and refractory acute myeloid leukemia.
Robak T; Wrzesień-Kuś A
Leuk Lymphoma; 2002 Feb; 43(2):281-91. PubMed ID: 11999559
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of childhood acute myelogenous leukemia.
Ebb DH; Weinstein HJ
Pediatr Clin North Am; 1997 Aug; 44(4):847-62. PubMed ID: 9286288
[TBL] [Abstract][Full Text] [Related]
16. New strategies for the treatment of adult acute myeloid leukemia.
McGee L
ONS Connect; 2007; 22(8 Suppl):65-6. PubMed ID: 17824571
[No Abstract] [Full Text] [Related]
17. Comparison of a fludarabine and melphalan combination-based reduced toxicity conditioning with myeloablative conditioning by radiation and/or busulfan in acute myeloid leukemia in Japanese children and adolescents.
Ishida H; Adachi S; Hasegawa D; Okamoto Y; Goto H; Inagaki J; Inoue M; Koh K; Yabe H; Kawa K; Kato K; Atsuta Y; Kudo K
Pediatr Blood Cancer; 2015 May; 62(5):883-9. PubMed ID: 25545836
[TBL] [Abstract][Full Text] [Related]
18. Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia.
Barrios M; Jiménez-Velasco A; Román-Gómez J; Madrigal ME; Castillejo JA; Torres A; Heiniger A
Haematologica; 2003 Jul; 88(7):801-10. PubMed ID: 12857560
[TBL] [Abstract][Full Text] [Related]
19. Quantitative real-time RT-PCR detects elevated Wilms tumor gene (WT1) expression in autologous blood stem cell preparations (PBSCs) from acute myeloid leukemia (AML) patients indicating contamination with leukemic blasts.
Siehl JM; Thiel E; Leben R; Reinwald M; Knauf W; Menssen HD
Bone Marrow Transplant; 2002 Mar; 29(5):379-81. PubMed ID: 11919726
[TBL] [Abstract][Full Text] [Related]
20. Unanswered questions in acute myeloid leukaemia.
Ferrara F
Lancet Oncol; 2004 Jul; 5(7):443-50. PubMed ID: 15231251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
